参考文献/References:
[1]WELLER M, VAN DEN BENT M, PREUSSER M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood [J]. Nat Rev Clin Oncol, 2021, 18(3): 170-186.
[2]SUN W, ZHOU H, HAN X, et al. Circular RNA: a novel type of biomarker for glioma (Review) [J]. Mol Med Rep, 2021, 24(2): 602.
[3]DEWITT JC, MOCK A, LOUIS DN. The 2016 WHO classification of central nervous system tumors: what neurologists need to know [J]. Curr Opin Neurol, 2017, 30(6): 643-649.
[4]WELLER M, VAN DEN BENT M, TONN JC, et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas [J]. Lancet Oncol, 2017, 18(6): e315-e329.
[5]HICKS WH, BIRD CE, TRAYLOR JI, et al. Contemporary mouse models in glioma research [J]. Cells, 2021, 10(3): 712.
[6]WANG F, ZHU T, GUAN XY, et al. Mechanism of elemene enhancing radiosensitivity of human glioma U251 cells [J]. Chin J Pathophysiol, 2020, 36(4): 707-712. 汪 凤，朱 婷，关晓燕，等. β-榄香烯对人胶质瘤U251细胞的放射增敏机制[J]. 中国病理生理杂志，2020，36（4）：707-712.
[7]ZHAO HL, WANG LL, LUO DD, et al. Construction of temozolomide resistant glioma cell lines and the study of the reversal of drug resistance by elemene [J]. Chin J Stereotact Funct Neurosurg, 2020, 33(5): 271-274. 赵海林，王璐璐，罗冬冬，等. 替莫唑胺耐药胶质瘤细胞株的构建及β-榄香烯逆转其耐药性的研究[J]. 立体定向和功能性神经外科杂志，2020，33(5)：271-274.
[8]BAI R, ZHU J, BAI Z, et al. Second generation beta-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma [J]. J Enzyme Inhib Med Chem, 2022, 37(1): 379-385.
[9]ZHAI B, ZHANG N, HAN X, et al. Molecular targets of beta-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review [J]. Biomed Pharmacother, 2019, 114: 108812.
[10]ZHAI B, ZENG Y, ZENG Z, et al. Drug delivery systems for elemene, its main active ingredient beta-elemene, and its derivatives in cancer therapy [J]. Int J Nanomedicine, 2018, 13: 6279-6296.
[11]YAO YQ, XU YH, LU J, et al. Effect of p38 MAPK on elemene-induced cell cycle arrest in C6 glioblastoma cells [J]. Zhonghua Yi Xue Za Zhi, 2008, 88(1): 56-58. 姚轶群，徐英辉，卢 军，等. p38在榄香烯致鼠胶质瘤C6细胞周期阻滞中的作用[J]. 中华医学杂志，2008，8（1）：56-58.
[12]ZHU T, ZHAO Y, ZHANG J, et al. β-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6 [J]. Int J Oncol, 2011, 38(2): 419-426.
[13]ZHU TZ, LI XM, LUO LH, et al. Beta-elemene inhibits proliferation through crosstalk between glia maturation factor beta and extracel-lular signalregulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells [J]. Mol Med Rep, 2014, 10(2): 1122-1128.
[14]HANSEN CG, NG YL, LAM WL, et al. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1 [J]. Cell Res, 2015, 25(12): 1299-1313.
[15]COFFMAN JA. Cell cycle development [J]. Dev Cell, 2004, 6(3): 321-327.
[16]YANG D, XU X, WANG X, et al. Beta-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling [J]. Am J Cancer Res, 2021, 11(2): 370-388.
[17]QIAO L, WONG BC. Targeting apoptosis as an approach for gastro-intestinal cancer therapy [J]. Drug Resist Updat, 2009, 12(3): 55-64.
[18]LI QQ, LEE RX, LIANG H, et al. Anticancer activity of beta-elemene and its synthetic analogs in human malignant brain tumor cells [J]. Anticancer Res, 2013, 33(1): 65-76.
[19]LI CL, CHANG L, GUO L, et al. Beta-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2 [J]. Asian Pac J Cancer Prev, 2014, 15(23): 10407-10412.
[20]SIMON HU, HAJ-YEHIA A, LEVI-SCHAFFER F. Role of reactive oxygen species (ROS) in apoptosis induction [J]. Apoptosis, 2000, 5 (5): 415-418.
[21]KANG SH, YU MO, PARK KJ, et al. Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma [J]. Neurosurgery, 2010, 67(5): 1386-1395.
[22]CAI SZ, XIONG QW, ZHAO LN, et al. Beta-elemene triggers ROS-dependent apoptosis in glioblastoma cells through suppressing STAT3 signaling pathway [J]. Pathol Oncol Res, 2021, 27: 594299.
[23]FEI F, QU J, ZHANG M, et al. S100A4 in cancer progression and metastasis: a systematic review [J]. Oncotarget, 2017, 8(42): 73219-73239.
[24]VALASTYAN S, WEINBERG RA. Tumor metastasis: molecular insights and evolving paradigms [J]. Cell, 2011, 147(2): 275-292.
[25]MAHECHA AM, WANG H. The influence of vascular endothelial growth factor-a and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer [J]. Onco Targets Ther, 2017, 10: 4617-4624.
[26]GUO JZ, JI HM, ZHANG GL, et al. Experimental study on antiangiogenesis effect of β-Elemene in glioma grafted rabbit cornea model [J]. China J Modern Med, 2014, 24(14): 38-41. 郭建忠，吉宏明，张刚利，等. β-榄香烯抑制胶质瘤兔角膜移植模型血管生成的实验研究[J]. 中国现代医学杂志，2014，24（14）：38-41.
[27]LI YF, LI MJ, LIAN XY, et al. Effect of the combination of elemene and VEGF polyclonal antibodies on the proliferation of rat gliomas [J]. Heilongjiang Med Pharm, 2015, 38(6): 99-100. 李英夫，李明军，廉晓宇，等. β-榄香烯和VEGF多克隆抗体联合应用对大鼠脑胶质瘤增殖的影响[J]. 黑龙江医药科学，2015，38(6): 99-100.
[28]ZHU T, LI X, LUO L, et al. Reversion of malignant phenotypes of human glioblastoma cells by beta-elemene through beta-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules [J]. J Transl Med, 2015, 13: 356.
[29]YU X, XU M, LI N, et al. Beta-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer [J]. Biochem Biophys Res Commun, 2017, 490(2): 514-520.
[30]MA C, ZHOU W, YAN Z, et al. Beta-elemene treatment of glioblastoma: a single-center retrospective study [J]. Onco Targets Ther, 2016, 9: 7521-7526.
[31]ZHANG X, CHEN Y, YAO J, et al. Beta-elemene combined with temozolomide in treatment of brain glioma [J]. Biochem Biophys Rep, 2021, 28: 101144.
[32]MU L, WANG T, CHEN Y, et al. Beta-elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway [J]. Int J Oncol, 2016, 49(4): 1427-1436.
[33]WANG H, MU X, HE H, et al. Cancer radiosensitizers [J]. Trends Pharmacol Sci, 2018, 39(1): 24-48.
[34]LIU S, ZHOU L, ZHAO Y, et al. Beta-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway [J]. Oncol Rep, 2015, 34(2): 943-951.
[35]ZOU K, LI Z, ZHANG Y, et al. Beta-elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway [J]. Aging (Albany NY), 2020, 13(2): 2575-2592.
[36]SINGH SS, VATS S, CHIA AY, et al. Dual role of autophagy in hall-marks of cancer [J]. Oncogene, 2018, 37(9): 1142-1158.
[37]GUAN C, LIU W, YUE Y, et al. Inhibitory effect of beta-elemene on human breast cancer cells [J]. Int J Clin Exp Pathol, 2014, 7(7): 3948-3956.
[38]WANG GY, ZHANG L, GENG YD, et al. Beta-elemene induces apoptosis and autophagy in colorectal cancer cells through regulating the ROS/AMPK/mTOR pathway [J]. Chin J Nat Med, 2022, 20 (1): 9-21.
相似文献/References:
[1]谢宝树 张 林 王 宇 贾 锋 殷玉华.复发性多发胶质母细胞瘤的预后分析[J].中国临床神经外科杂志,2016,(06):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
XIE Bao-shu,ZHANG Lin,WANG Yu,et al.Analysis of prognoses in patients with recurrent multiple glioblastomas[J].,2016,(05):333.[doi:10.13798/j.issn.1009-153X.2016.06.005]
[2]宋贵东 综述 高之宪 审校.贝伐单抗治疗复发胶质母细胞瘤的研究进展[J].中国临床神经外科杂志,2015,(10):638.[doi:10.13798/j.issn.1009-153X.2015.10.022]
[3]李继强 杨吉安 邵灵敏 吴庭枫 刘宝辉 陈谦学.稳定低表达BAG3的胶质母细胞瘤U87细胞株的构建及鉴定[J].中国临床神经外科杂志,2015,(06):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
LI Ji-qiang,YANG Ji-an,SHAO Ling-min,et al.Construction and identification of U87 glioblastoma cell strain with a stable low expression of BAG3[J].,2015,(05):353.[doi:10.13798/j.issn.1009-153X.2015.06.011]
[4]桂志勇 冯 军 黄俊红 白敬洋.靶向沉默c-fos基因表达对胶质瘤U87MG细胞增殖与侵袭的影响[J].中国临床神经外科杂志,2017,(12):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
GUI Zhi-yong,FENG Jun,HUANG Jun-hong,et al.Effects of c-fos targeted silence on proliferation and invasiveness of human glioma cell U87[J].,2017,(05):834.[doi:10.13798/j.issn.1009-153X.2017.12.011]
[5]王娇燕 孟凡华 刘魏然 魏春晓 林丽萍.SWI在胶质母细胞瘤与单发脑转移瘤鉴别中的价值[J].中国临床神经外科杂志,2018,(01):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
WANG Jiao-yan,MENG Fan-hua,LIU Wei-ran,et al.Value of susceptibility-weighted imaging in differentiative diagnosis of glioblastomas and solitary brain metastases[J].,2018,(05):13.[doi:10.13798/j.issn.1009-153X.2018.01.005]
[6]张治元 王汉东 樊友武 贾 玥 吴晋蓉.胶质肉瘤15例分析及文献复习[J].中国临床神经外科杂志,2018,(02):69.
ZHANG Zhi-yuan,WANG Han-dong,FAN You-wu,et al.Diagnosis and treatment of gliosarcoma: a report of 15 cases and literature review[J].,2018,(05):69.
[7]郑锐哲 姜秀峰 陈二涛 孙兆良 冯东福.胶质母细胞瘤卒中术后继发硬膜下水瘤1例[J].中国临床神经外科杂志,2019,(02):128.[doi:10.13798/j.issn.1009-153X.2019.02.022]
[8]胡 玥,薛小燕,李子超,等.阿苯达唑抑制胶质瘤裸鼠模型肿瘤生长[J].中国临床神经外科杂志,2019,(06):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
HU Yue,XUE Xiao-yan,LI Zi-chao,et al.Albendazole inhibits tumor growth in nude mice model of glioma[J].,2019,(05):348.[doi:10.13798/j.issn.1009-153X.2019.06.010]
[9]殷安安 陆 南 贺亚龙 章 翔 刘玉河.TRIM38基因非CpG岛DNA甲基化与胶质母细胞瘤临床预后的关系[J].中国临床神经外科杂志,2020,(02):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
YIN An-an,LU Nan,HE Ya-long,et al.Impacts of TRIM38 non-CpG island DNA methylation alterations on clinical prognosis in patients with glioblastomas[J].,2020,(05):76.[doi:10.13798/j.issn.1009-153X.2020.02.005]
[10]吴 蛟 易 勇 赵卓琳 周良学 周世军.贝伐珠单抗联合化疗治疗胶质母细胞瘤的meta分析[J].中国临床神经外科杂志,2020,(02):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]
WU Jiao,YI Yong,ZHAO Zhuo-lin,et al.Efficacy and safety of bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis[J].,2020,(05):82.[doi:10.13798/j.issn.1009-153X.2020.02.007]